We also found significant differences in TN-R and NF-M levels between FTD and AD patients, suggesting that TN-R and NF-M could be used not only as general markers for neurodegeneration, but more specifically have the potential to separate between different pathologies. This evidence concerns the gene NEFM and Alzheimer disease.